Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Axonics Modulation Technologies, Inc.    AXNX

AXONICS MODULATION TECHNOLOGIES, INC.

(AXNX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2020 03/24/2020 03/25/2020 03/26/2020 03/27/2020 Date
18.37(c) 20.97(c) 22.31(c) 22.83(c) 22.61(c) Last
504 703 615 475 431 127 603 989 309 584 Volume
+1.16% +14.15% +6.39% +2.33% -0.96% Change
More quotes
Financials (USD)
Sales 2020 86,9 M
EBIT 2020 -61,1 M
Net income 2020 -62,1 M
Finance 2020 117 M
Yield 2020 -
Sales 2021 156 M
EBIT 2021 -23,9 M
Net income 2021 -24,8 M
Finance 2021 86,6 M
Yield 2021 -
P/E ratio 2020 -11,6x
P/E ratio 2021 -29,6x
EV / Sales2020 7,58x
EV / Sales2021 4,41x
Capitalization 775 M
More Financials
Company
Axonics Modulation Technologies, Inc. is a medical technology company. The Company is focused on the design, development, and commercialization of sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder (OAB), fecal incontinence (FI), and... 
More about the company
Surperformance© ratings of Axonics Modulation Technol
Trading Rating : Investor Rating :
More Ratings
Latest news on AXONICS MODULATION TECHNOL
03/16AXONICS MODULATION TECHNOLOGIES : ® Announces Filing of Petitions Before the Uni..
BU
03/04AXONICS MODULATION TECHNOLOGIES, INC : Results of Operations and Financial Condi..
AQ
03/04AXONICS MODULATION TECHNOLOGIES : ® Announces Fourth Quarter and Fiscal 2019 Fin..
BU
02/28AXONICS MODULATION TECHNOLOGIES, INC : annual earnings release
02/25AXONICS MODULATION TECHNOLOGIES : ® to Present at the Barclays Global Healthcare..
BU
02/19AXONICS MODULATION TECHNOLOGIES : ® to Report 2019 Fourth Quarter and Full-Year ..
BU
02/11AXONICS MODULATION TECHNOLOGIES : ® to Present at the SVB Leerink Global Healthc..
BU
02/04AXONICS MODULATION TECHNOLOGIES : ® Sacral Neuromodulation System Receives Reimb..
BU
01/21AXONICS MODULATION TECHNOLOGIES : ® Announces FDA Approval of Enhanced Neurostim..
BU
01/09AXONICS MODULATION TECHNOLOGIES, INC : Results of Operations and Financial Condi..
AQ
01/09AXONICS MODULATION TECHNOLOGIES : ® Announces Preliminary Fourth Quarter and Ful..
BU
01/02AXONICS MODULATION TECHNOLOGIES, INC : Entry into a Material Definitive Agreemen..
AQ
2019AXONICS MODULATION TECHNOLOGIES : ® Granted Six U.S. Patents and Allowed Three A..
BU
2019AXONICS MODULATION TECHNOLOGIES, INC : Other Events, Financial Statements and Ex..
AQ
2019AXONICS MODULATION TECHNOLOGIES : ® Announces Full Exercise of Underwriters' Opt..
BU
More news
News in other languages on AXONICS MODULATION TECHNOL
03/16AXONICS MODULATION TECHNOLOGIES : ® annonce avoir déposé des pétitions devant l'..
03/16AXONICS MODULATION TECHNOLOGIES : ® kündigt die Einreichung von Petitionen vor d..
02/28AXONICS MODULATION TECHNOLOGIES, INC : Veröffentlichung des Jahresergebnisses
02/28AXONICS MODULATION TECHNOLOGIES, INC : publication des résultats annuels
02/04AXONICS MODULATION TECHNOLOGIES : Le système de neuromodulation sacrée Axonics® ..
More news
Chart AXONICS MODULATION TECHNOLOGIES, INC.
Duration : Period :
Axonics Modulation Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AXONICS MODULATION TECHNOL
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 45,63  $
Last Close Price 22,61  $
Spread / Highest target 121%
Spread / Average Target 102%
Spread / Lowest Target 59,2%
EPS Revisions
Managers
NameTitle
Raymond Wayne Cohen Chief Executive Officer & Director
Danny L. Dearen President & Chief Financial Officer
Raphaël Wisniewski Chairman
Rinda K. Sama Chief Operating Officer
Guang Qiang Jiang Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
AXONICS MODULATION TECHNOLOGIES, INC.-18.40%775
STRYKER CORPORATION-24.16%61 221
SMITH & NEPHEW PLC-22.10%14 867
WRIGHT MEDICAL GROUP N.V.-4.86%3 700
AK MEDICAL HOLDINGS LIMITED-3.38%2 260
GLAUKOS CORPORATION-38.79%1 627